March 25

AMA-JAMA to Investigate Following AHRP Complaint

ama_logo.jpg

 

 

FOR IMMEDIATE RELEASE                                                        March 27, 2009

AMA REQUESTS JOURNAL OVERSIGHT COMMITTEE REVIEW

Statement attributable to: Joseph M. Heyman, M.D.
AMA Board Chair

 

"The American Medical Association is owner and publisher of the Journal of the American Medical Association (JAMA) and its specialty Archives journals. While we are ultimately responsible for these publications, as most in the medical and journalism professions are aware, these journals are editorially independent of AMA. That means we do not review or interfere in what is printed in these journals.

"Recently, concerns have been raised over how JAMA editors addressed a conflict of interest issue   brought to light by Professor Jonathan Leo. As owner and publisher of JAMA, we take these concerns very seriously.

"In accordance with the Editorial Governance Plan for JAMA, this entire matter is being formally referred to the Journal Oversight Committee (JOC). The AMA is requesting that the JOC examine the concerns related to Professor Leo’s inquiry and upon completion present its findings to the AMA Board of Trustees. The AMA Board will give careful consideration to whatever is reported to it by the JOC."

  ###

Contact:
AMA Media Relations
(312) 464-4430                                                                      

AHRP Letter of Complaint 


Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.


You may also like

October 18, 2024

Vera Sharav is a Holocaust survivor and founder of the Alliance for Human Research Protection. She’s spent

Read More
To Obey or Not Obey with Holocaust Survivor Vera Sharav

October 18, 2024

PART 1: “Why are you anti-war? Because war is anti-human. Palestine is a globalist genocide.” Vera Sharav.

Read More
Palestine – A Globalist Genocide – WAGE PEACE with Shabnam Palesa Mohamed and Vera Sharav (Part 1/3)